TBX21 and malaria: More than 95% of the expanded clones sharing identical TCR clonotypes in protected participants during a malaria illness, expressed a robust TH1 cytolytic effector program including transcripts encoding for multiple lytic effector proteins and the TFs ZEB2, T-BET, and RUNX3 (cluster 1).